K-numberK251105
Device nameTetra (TM-20); Tetra (TM-50)
ApplicantEmed Technologies Corporation
Product codePKP
Device classClass II
Decision dateDec 22, 2025
DecisionSubstantially Equivalent
Regulation880.5725
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The Tetra Micro Infusion System is a battery-powered, reusable subcutaneous infusion pump designed for home and hospital use in adults and children 2 years and older. It delivers prescription liquid medicines, specifically Hizentra (immune globulin), by applying controlled pneumatic pressure to a syringe connected to sterile patient administration sets. Two models are available: TM-20 for 20mL syringes and TM-50 for 50mL syringes (or smaller sizes with an adapter).

Technological characteristics

The device uses a pneumatic pump to apply controlled pressure (2.50–7.00 psig) to the syringe gasket with five discrete pressure settings. It incorporates embedded firmware and microcontroller-based control, a rechargeable lithium-ion battery, LED and audible notifications for status and alarms, and a membrane keypad interface. Unlike the primary predicate (SCIg60) which uses a mechanical spring, the Tetra Micro employs battery-powered pneumatic control; like the secondary predicate (Crono), it uses software control and electronic feedback. Flow rate is not directly measured but determined by applied pressure, fluid viscosity, and downstream resistance.

Test standards cited

Not stated in this summary.

Substantial equivalence argument

Substantial equivalence is established through combined comparison to two predicates. The primary predicate (SCIg60, K240148) is equivalent in delivery method—both apply pressure to displace syringe fluid through passive administration sets without direct flow measurement. The secondary predicate (Crono S-PID 50, K091042) supports equivalence in battery-powered, firmware-controlled architecture and electronic feedback systems. Although the Tetra Micro uses pneumatic rather than mechanical (spring) or motor-driven pressure, the functional outcome, syringe-based delivery mechanism, compatible administration sets, and comparable flow characteristics demonstrate safety and performance equivalence. Non-clinical testing (infuser pressure, drug-device compatibility, flow verification, electrical safety, software validation, and usability) supports this determination.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →